Skip to content

    GSP Crop Science Q1 FY27 earnings call

    GSPCROP
    Chemicals·12 Aug 2026
    Management Summary

    GSP Crop Science Limited reported a stable Q1 FY27 with revenue of ₹386 crores, up 2.39% YoY, and PAT of ₹26.4 crores, a 16% increase. The PAT growth was notably boosted by a one-time land sale gain. Gross margins improved due to a strategic shift towards specialty products, and the company's credit rating was upgraded. However, challenges persist from raw material volatility, international demand softness, and the non-recurring nature of the other income.

    Highlights

    5
    • Revenue grew to ₹386 crores in Q1 FY27, a 2.39% increase YoY, driven by strong domestic business momentum.

    • PAT increased by 16% to ₹26.4 crores, supported by improved gross margins from a shift towards specialty and differentiated products.

    • Gross margins improved due to a favorable product mix, focusing on higher-margin specialty products.

    • ICRA upgraded the company's credit rating from A to A+ stable, reflecting improved financial health and loan repayments from IPO funds.

    • Material supply constraints, a concern in the previous quarter, have been mitigated, and the monsoon has been supportive for the Kharif season.

    Concerns

    5
    • Revenue growth of 2.39% YoY is modest, with international business partly offset by temporary raw material constraints.

    • PAT growth of 16% was significantly influenced by a one-time other income of ₹5.7 crores from a land sale, without which PBT would have been roughly flat YoY.

    • Raw material prices experienced volatility due to geopolitical situations and a 10-11% depreciation of the rupee, impacting costs.

    • Demand in Brazil, a key international market, is under pressure due to pricing volatility and liquidity issues, leading to delayed buying patterns.

    • In the B2C segment, there is a time lag in passing on increased raw material costs to customers, potentially affecting margins.

    Key financials

    Single quarter

    04 metrics
    1. 01Revenue₹386 Cr+2.4%YoY
    2. 02PAT₹26.4 Cr+16%YoY
    3. 03EBITDA Margin11%
    4. 04Other Income (Land Sale)₹5.7 Cr

    Capital allocation

    2
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Debt

    Debt disclosed

    Guidance & targets

    11
    CategoryTargetPriority
    Product Mix
    Patented product share in B2C
    Double current share
    High
    New Products
    New technical products
    1-2 products
    High
    New Products
    New patented formulations
    2-3 formulations
    High
    Revenue
    Revenue growth rate
    15%
    Medium
    Profitability
    EBITDA growth
    13-14%
    Medium
    Profitability
    EBITDA margin
    12-13%
    Medium
    Market Share
    Domestic market share
    7-8%
    Medium
    Business Mix
    Domestic B2C share
    45-50%
    Medium
    Business Mix
    Domestic B2B share
    30-35%
    Medium
    Business Mix
    Export share
    20%
    Medium
    Q2 Performance
    Q2 PAT contribution to full year
    Similar to last year (~60%)
    Medium

    What to watch in Q2 FY27

    5

    IPO account closure

    within 2-3 months
    CurrentPending settlement from banks for brokerages
    TargetClosed

    Why it matters

    Indicates full utilization of IPO funds and completion of the IPO process.

    Once we get an exact working for that expense relating to the brokerage which in my understanding takes 2 months to 3 months from individual banks, then we'll be able to close the IPO account.

    Risks & concerns

    5
    RiskSeverity

    Impact of one-time income on PAT

    Q1 FY27 PAT growth of 16% was significantly boosted by a ₹5.7 crore gain from a land sale, making underlying PBT growth roughly flat YoY.Analyst acknowledged

    medium

    Raw material price volatility and currency depreciation

    Geopolitical situations, petrochemical links, and 10-11% rupee depreciation led to volatile raw material prices, with a time lag in passing costs in B2C.Management acknowledged

    medium

    Demand and liquidity issues in Brazil

    Brazil, a major export market, faces demand pressure due to pricing volatility and liquidity challenges, impacting buying patterns and potentially H2 exports.Management acknowledged

    medium

    Competition from China in exports

    China's better logistics model led to some orders being transferred away from GSP despite competitive pricing.Management acknowledged

    low

    Regional demand softness in South India

    Andhra, Telangana, and Karnataka are in a 'wait and watch' situation regarding monsoon, potentially affecting regional demand.Management acknowledged

    low

    Q&A highlights

    7

    “out of these INR8 crores, almost INR5.7 crores is this other income for the land sale that is under consideration which you specifically mentioned. There is no other income that we plan that will be there in the upcoming quarters. This is a one-off event which we don't expect in the remaining three quarters”

    Revealed that a significant portion of the reported PAT growth was due to a non-recurring land sale, implying underlying PBT growth was flat YoY without it.

    asked by Ayushi

    3 min read7 chapters

    Detailed Narrative

    01

    Q1 FY27 Financial Performance Overview

    GSP Crop Science Limited reported a stable Q1 FY27 with revenue reaching ₹386 crores, marking a modest 2.39% year-on-year growth from ₹377 crores in Q1 FY26. Profit After Tax (PAT) increased by 16% to ₹26.4 crores. The company's EBITDA margin stood at 11% for the quarter. This performance was achieved despite volatile operating environments and temporary raw material constraints in the international business.

    02

    Impact of One-Time Other Income on Profitability

    The reported 16% PAT growth was significantly influenced by a one-time📎 other income of ₹5.7 crores from a land sale. An analyst noted that excluding this gain, the Profit Before Tax (PBT) would have been roughly flat compared to last year's ₹29 crores. Management confirmed this was a one-off📎 event and not expected to recur in the remaining quarters, indicating that underlying operational profitability growth was more subdued.

    03

    Strategic Shift Towards Patented and Differentiated Products

    The company is actively shifting its product mix towards specialty and differentiated products, which contributed to improved gross margins. Patented products currently constitute 20-22% of the B2C business, with a target to double this share over the next three years. This strategy aims to enhance margins and provide a competitive edge against generic offerings, supported by a robust R&D pipeline for new technical and patented formulation products.

    04

    Capacity Utilization and R&D Pipeline

    Current technical capacity utilization is at 70-75%, offering scope for growth and product swapping to accommodate high-value, low-volume products. Formulation capacity utilization is lower at 25-30% but is not a bottleneck due to its simpler process and peak season design. The R&D pipeline is strong, with plans to introduce 1-2 new technical products annually for the next five years and 2-3 new patented formulations annually for the next 4-5 years, including new herbicide and potato-specific products.

    05

    International Business Challenges and Strategy

    The international business, particularly in Brazil, faces significant demand pressure due to pricing volatility and liquidity issues, leading to delayed buying patterns. Competition from China, with its better logistics, also impacted some orders. Management is focusing on established B2B customers in Brazil and exploring smaller pockets in Latin America (Argentina, Uruguay) through second-tier distributors. The long-term strategy involves running technical plants for 12 months by leveraging reverse seasons in Latin America.

    06

    Domestic Market Outlook and Farmer Behavior

    The domestic market shows strong momentum, with a positive outlook for Q2 FY27 due to a good monsoon and increased acreage for key crops like cotton, soybean, and chilies. Farmer behavior is evolving, with increased awareness of specialty chemicals and a shift towards preventive spraying, which benefits GSP's strong insecticide and fungicide portfolio. The company aims to scale its domestic market share from the current 3-3.5% to 7-8%.

    07

    Credit Rating Upgrade and Debt Management

    ICRA upgraded GSP Crop Science Limited's credit rating from A to A+ stable for long-term and A1 for short-term facilities. This upgrade is primarily attributed to the repayment of loans using IPO funds and sustained good company performance. The reduction in interest costs due to debt repayment is also expected to contribute to future PAT margin improvements.

    This is an AI-generated summary of a publicly available earnings call transcript.